These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 21436085)
21. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate. Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614 [TBL] [Abstract][Full Text] [Related]
22. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690 [TBL] [Abstract][Full Text] [Related]
23. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Turkbey B; Pinto PA; Mani H; Bernardo M; Pang Y; McKinney YL; Khurana K; Ravizzini GC; Albert PS; Merino MJ; Choyke PL Radiology; 2010 Apr; 255(1):89-99. PubMed ID: 20308447 [TBL] [Abstract][Full Text] [Related]
24. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891 [TBL] [Abstract][Full Text] [Related]
25. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer. Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657 [TBL] [Abstract][Full Text] [Related]
27. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting. Mazaheri Y; Vargas HA; Akin O; Goldman DA; Hricak H J Magn Reson Imaging; 2012 Mar; 35(3):660-8. PubMed ID: 22069141 [TBL] [Abstract][Full Text] [Related]
28. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849 [TBL] [Abstract][Full Text] [Related]
29. Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology. Kwak JT; Sankineni S; Xu S; Turkbey B; Choyke PL; Pinto PA; Moreno V; Merino M; Wood BJ Radiology; 2017 Oct; 285(1):147-156. PubMed ID: 28582632 [TBL] [Abstract][Full Text] [Related]
30. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440 [TBL] [Abstract][Full Text] [Related]
31. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Turkbey B; Shah VP; Pang Y; Bernardo M; Xu S; Kruecker J; Locklin J; Baccala AA; Rastinehad AR; Merino MJ; Shih JH; Wood BJ; Pinto PA; Choyke PL Radiology; 2011 Feb; 258(2):488-95. PubMed ID: 21177390 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767 [TBL] [Abstract][Full Text] [Related]
33. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings. Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768 [TBL] [Abstract][Full Text] [Related]
34. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T. Dong Y; Liu Q J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661 [TBL] [Abstract][Full Text] [Related]
35. Validation of quantitative analysis of multiparametric prostate MR images for prostate cancer detection and aggressiveness assessment: a cross-imager study. Peng Y; Jiang Y; Antic T; Giger ML; Eggener SE; Oto A Radiology; 2014 May; 271(2):461-71. PubMed ID: 24533870 [TBL] [Abstract][Full Text] [Related]
36. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. Barrett T; Vargas HA; Akin O; Goldman DA; Hricak H Radiology; 2012 Jun; 263(3):751-7. PubMed ID: 22474673 [TBL] [Abstract][Full Text] [Related]
37. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. Bogner W; Pinker K; Zaric O; Baltzer P; Minarikova L; Porter D; Bago-Horvath Z; Dubsky P; Helbich TH; Trattnig S; Gruber S Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078 [TBL] [Abstract][Full Text] [Related]
38. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981 [TBL] [Abstract][Full Text] [Related]
39. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness. Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916 [TBL] [Abstract][Full Text] [Related]
40. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging. Woo S; Cho JY; Kim SY; Kim SH AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]